炎症体:在补充性腺炎中新兴的治疗点?
Ciara Campbell1,2,3, Jay M Mayatra1, Ashish J Neve4
1Discipline of Anatomy, Trinity College Dublin, Dublin, Ireland.
The British journal of dermatology
|June 24, 2024
概括
炎症体,关键的免疫传感器,在补充性腺炎 (HS) 病原发生过程中发挥着重要作用. 准这些炎症组复合体为HS治疗提供了一个有前途的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病,影响毛囊.
- HS涉及屏障功能障碍和异常免疫激活,炎症体与其病理生理学有关.
- 炎症体是多蛋白质复合体,由危险信号激活,通过IL-1β等细胞因子驱动炎症.
研究的目的:
- 审查炎症体在补充性水炎的发病过程中的作用.
- 评估炎症体作为HS的潜在治疗点.
主要方法:
- 文献综述总结了目前关于HS炎症酶的研究.
- 分析涉及炎症体及其下游细胞因子的信号通路.
- 对针对炎症体通路的现有和潜在免疫疗法的评估.
主要成果:
- 证据支持HS病变发生时的炎症酶激活.
- 炎症酶激活导致促炎性细胞因子的释放,包括IL-1β和IL-17.
- 准炎症酶可以调节HS中的多个炎症途径.
结论:
- 炎症酶是HS的关键参与者.
- 准炎症酶是一种可行的治疗途径,用于中度至重度的HS.
- 在HS治疗中,需要对炎症酶向疗法的进一步研究.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130
Inflammatory Bowel Disease IV: Pharmacological Management
125
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
125
Inflammation
53.3K
Overview
53.3K


